If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Directorate Changes

5 Jul 2017 07:00

RNS Number : 1247K
Cenkos Securities PLC
05 July 2017
 



5 July 2017

 

Cenkos Securities plc

("Cenkos" or the "Company")

 

Directorate Changes

As reported on 12 May 2017, Jim Durkin, the Company's Chief Executive Officer had informed the Company of his intention to retire from the Company. The Company has since undertaken a search for a successor to Jim Durkin.

Following the completion of this search, Cenkos is pleased to announce that, subject to FCA approval, Anthony Hotson is to be appointed as an Executive Director and to the position of Chief Executive Officer with effect from 1 August 2017. Anthony Hotson has been a Non-Executive Director of the Company since May 2012.

Jim Durkin will resign from the Board and from the position of Chief Executive Officer on 1 August 2017 and will leave the Company on 31 December 2017.

Anthony has extensive experience in financial services having previously worked for the Bank of England, McKinsey & Company and S.G. Warburg. He started his career in the Economics Division of the Bank of England, subsequently moving to the Governors' Office and Money Markets Division. In 1986, he was seconded to the newly-formed Building Societies Commission as Assistant Commissioner. Thereafter, he was employed by McKinsey & Company before joining the corporate finance division of S.G. Warburg. He was a Director of S.G. Warburg & Co. Ltd. from 1992 to 1995 and subsequently Managing Director and Head of the Financial Institutions Group, SBC Warburg (subsequently UBS) until 1998. Following this he served as Non-Executive director in the insurance, fund management and banking sectors, including as a Non-Executive Director of Henderson Group plc where he was a member of the group board and Chairman of its subsidiary companies, London Life and Towry Law. Anthony is Deputy Director of the Centre for Financial History and a senior member of Darwin College, Cambridge.

Gerry Aherne, Chairman said:

"The Board would like to thank Jim for all his hard work and the significant contribution that he has made to the development of the business and he will leave with our best wishes."

"I have every confidence in Anthony in leading the Company going forward as the Company's new Chief Executive Officer. Anthony is exceptionally well placed to undertake the role and his wealth of experience will be a valuable asset for the Company in his new executive role. Having been a director of the Company since May 2012, Anthony has previously been involved in reviewing the firm's structure, governance and processes, including the impact that changing regulations may have, and he has been actively involved with the management of the Company in this respect. "

 

Enquiries:

 

Jim Durkin +44 20 7397 8900

Chief Executive Officer

Cenkos Securities plc

 

Dr Azhic Basirov / David Jones / Ben Jeynes +44 20 7131 4000

Nominated Adviser

Smith & Williamson Corporate Finance Limited

 

David Rydell / Duncan Mayall +44 20 3772 2496

Bell Pottinger

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABLGDRUSGBGRS
Date   Source Headline
19th Feb 201810:00 amRNSForm 8.5 (EPT/NON-RI)
15th Feb 201811:26 amRNSEBT Share Purchase
15th Feb 20189:41 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20189:32 amRNSForm 8.5 (EPT/NON-RI)
6th Feb 20185:46 pmRNSHolding(s) in Company
6th Feb 201810:36 amRNSForm 8.5 (EPT/NON-RI)
5th Feb 20189:18 amRNSHolding(s) in Company
31st Jan 20189:37 amRNSFurther re Directorate Change
29th Jan 201810:49 amRNSHolding(s) in Company
29th Jan 201810:48 amRNSHolding(s) in Company
29th Jan 20189:37 amRNSForm 8.5 (EPT/NON-RI)
26th Jan 20181:59 pmRNSDirector/PDMR Shareholding
26th Jan 20187:00 amRNSEBT Share Purchase
25th Jan 20183:35 pmRNSTransaction in Own Shares
24th Jan 201810:31 amRNSForm 8.5 (EPT/NON-RI)
23rd Jan 201810:35 amRNSForm 8.5 (EPT/NON-RI)
22nd Jan 20189:35 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 20189:58 amRNSForm 8.5 (EPT/NON-RI)
18th Jan 201810:00 amRNSForm 8.5 (EPT/NON-RI)
17th Jan 20189:28 amRNSForm 8.5 (EPT/NON-RI)
16th Jan 20189:50 amRNSForm 8.5 (EPT/NON-RI)
15th Jan 20189:34 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 201811:11 amRNSForm 8.5 (EPT/NON-RI)
11th Jan 20189:18 amRNSForm 8.5 (EPT/NON-RI)
10th Jan 20189:23 amRNSForm 8.5 (EPT/NON-RI)
9th Jan 20189:44 amRNSForm 8.5 (EPT/NON-RI)
9th Jan 20189:44 amRNSForm 8.5 (EPT/NON-RI)
8th Jan 20189:49 amRNSForm 8.5 (EPT/NON-RI)
5th Jan 201810:18 amRNSForm 8.5 (EPT/NON-RI)
4th Jan 201810:55 amRNSForm 8.5 (EPT/NON-RI)
3rd Jan 20189:58 amRNSForm 8.5 (EPT/NON-RI)
28th Dec 201710:59 amRNSForm 8.5 (EPT/NON-RI)
27th Dec 201710:55 amRNSForm 8.5 (EPT/NON-RI)
15th Dec 20179:58 amRNSForm 8.5 (EPT/NON-RI)
14th Dec 201710:16 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 201710:13 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 20172:58 pmRNSEBT Share Purchase
8th Dec 20172:30 pmRNSDirector/PDMR Shareholding
8th Dec 201711:48 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 201711:38 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 20171:20 pmRNSHolding(s) in Company
24th Nov 20177:00 amRNSDirector/PDMR Shareholding
22nd Nov 20177:00 amRNSDirector/PDMR Shareholding
16th Nov 20179:36 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20171:06 pmRNSDirector/PDMR Shareholding
15th Nov 20179:25 amRNSForm 8.5 (EPT/NON-RI)
13th Nov 20174:03 pmRNSFurther re Directorate Change
9th Nov 201710:44 amRNSForm 8.5 (EPT/NON-RI)
7th Nov 20175:08 pmRNSHolding(s) in Company
7th Nov 201710:25 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.